Moleculin to present at live! with webull corporate connect: healthcare investment webinar

Live webcast on wednesday, august 28 th at 3:40 pm et houston , aug. 26, 2024 /prnewswire/ -- moleculin biotech, inc., (nasdaq: mbrx) ("moleculin" or the "company"), a phase 3 clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that walter klemp, chairman and chief executive officer of moleculin will present at live! with webull corporate connect: healthcare investment webinar on wednesday, august 28, 2024 at 3:40 pm et.
LIVE Ratings Summary
LIVE Quant Ranking